An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

Bibliographic Details
Main Authors:	Littleton, E, Palace, J
Format:	Conference item
Published:	2005

Similar Items

Modafinil for multiple sclerosis fatigue: does it work?
by: Littleton, E, et al.
Published: (2010)

Assessing the impacts of L-carnitine and modafinil on fatigue in Iraqi multiple sclerosis patients
by: Ahmed Hamza Al-Shammari, et al.
Published: (2023-01-01)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
by: Bibani, R, et al.
Published: (2012)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
by: Bibani, R, et al.
Published: (2012)

An approach to the identification of targets of autoantibodies in multiple sclerosis
by: Littleton, E, et al.
Published: (2004)

Use of Modafinil in Psychiatric Disorders
by: Mehmet Hanifi Kokacya, et al.
Published: (2016-03-01)

Towards defining antigenic targets for antibodies in multiple sclerosis
by: Littleton, E, et al.
Published: (2006)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial
by: Spathis, A, et al.
Published: (2014)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
by: Spathis, A, et al.
Published: (2014)

New and old treatments for multiple sclerosis.
by: Palace, J
Published: (1998)

Comparison of effects of modafinil and caffeine on fatigue-vulnerable and fatigue-resistant aircrew after a limited period of sleep deprivation
by: Yara Q. Wingelaar-Jagt, et al.
Published: (2024-01-01)

New treatments and azathioprine in multiple sclerosis.
by: Palace, J, et al.
Published: (1997)

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
by: Talbot, K, et al.
Published: (2003)

Positive effect of modafinil on daytime somnolence on patients with Myotonic Dystrophy
by: Talbot, K, et al.
Published: (2002)

Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis
by: Smaranda Maier, et al.
Published: (2023-10-01)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

Modafinil decreases anxiety-like behaviour in zebrafish
by: Adrian Johnson, et al.
Published: (2017-02-01)

A randomised controlled trial of modafinil for treatment of daytime somnolence in myotonic dystrophy
by: Talbot, K, et al.
Published: (2003)

Making the diagnosis of multiple sclerosis.
by: Palace, J
Published: (2001)

Modafinil-excipient compatibility study using differential scanning calorimetry
by: Derar Omari, et al.
Published: (2023-01-01)

Effects of modafinil on emotional processing in first episode psychosis.
by: Scoriels, L, et al.
Published: (2011)

Cataplexy as a side effect of modafinil in a patient without narcolepsy
by: Eduardo Lopes, et al.
Published: (2014-03-01)

Simple Synthesis of Modafinil Derivatives and Their Anti-inflammatory Activity
by: Mankil Jung, et al.
Published: (2012-09-01)

Waking up to modafinil in shift work sleep disorder
by: Dilip Gude
Published: (2011-01-01)

The UK Multiple Sclerosis database.
by: Palace, J, et al.
Published: (1999)

Relationship of Smoking with Fatigue and Depression in Patients with Multiple Sclerosis
by: Yasemin Ekmekyapar Fırat, et al.
Published: (2021-09-01)

Study the Effect of Melatonin on Fatigue in Patients with Multiple Sclerosis
by: Farzaneh Fuladi Targhi, et al.
Published: (2018-12-01)

Treatments for fatigue in multiple sclerosis: A rapid and systematic review
by: Branas, P, et al.
Published: (2000)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
by: Brañas, P, et al.
Published: (2000)

Guidelines for differential diagnosis of suspected multiple sclerosis.
by: Palace, J
Published: (2009)

The Seasonal Fluctuation of Fatigue in Multiple Sclerosis
by: Matthias Grothe, et al.
Published: (2022-06-01)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 - The patients' perspective
by: Hilton-Jones, D, et al.
Published: (2012)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
by: Hilton-Jones, D, et al.
Published: (2012)

A multicenter, randomized, double-blinded, placebo-controlled trial of modafinil for lung cancer-related fatigue: Dose response and patient satisfaction data.
by: Fife, K, et al.
Published: (2013)

Modifying disability in progressive multiple sclerosis.
by: Palace, J, et al.
Published: (2014)

Modifying disability in progressive multiple sclerosis
by: Palace, J, et al.
Published: (2014)

Reduced clinical connectome fingerprinting in multiple sclerosis predicts fatigue severity
by: Lorenzo Cipriano, et al.
Published: (2023-01-01)

Modafinil-induced drug reaction with eosinophilia and systemic symptoms syndrome
by: Stacy Y. Kasitinon, MD, PhD, et al.
Published: (2022-09-01)

Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions
by: Jonathan P Wisor
Published: (2013-10-01)

Fatigue in multiple sclerosis and its relation with depression
by: M. Ben Abdallah, et al.
Published: (2022-06-01)